Balchem Corporation (BCPC) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Balchem Corporation stock (BCPC) is currently trading at $165.92. Balchem Corporation PE ratio is 34.93. Balchem Corporation PS ratio (Price-to-Sales) is 5.18. Analyst consensus price target for BCPC is $200.50. WallStSmart rates BCPC as Underperform.
- BCPC PE ratio analysis and historical PE chart
- BCPC PS ratio (Price-to-Sales) history and trend
- BCPC intrinsic value — DCF, Graham Number, EPV models
- BCPC stock price prediction 2025 2026 2027 2028 2029 2030
- BCPC fair value vs current price
- BCPC insider transactions and insider buying
- Is BCPC undervalued or overvalued?
- Balchem Corporation financial analysis — revenue, earnings, cash flow
- BCPC Piotroski F-Score and Altman Z-Score
- BCPC analyst price target and Smart Rating
Balchem Corporation
📊 No data available
Try selecting a different time range
BCPC Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Balchem Corporation (BCPC)
BCPC trades at a modest 9% premium above its Graham fair value of $163.78. Consider waiting for a pullback.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Balchem Corporation (BCPC) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in institutional own.. Concerns around peg ratio. Fundamentals are solid but monitor weak areas for improvement.
Balchem Corporation (BCPC) Key Strengths (2)
92.00% of shares held by major funds and institutions
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
Balchem Corporation (BCPC) Areas to Watch (8)
Very expensive relative to growth, significant premium
Premium valuation at 5.2x annual revenue
Premium pricing at 4.1x book value
Modest revenue growth at 9.80%
Moderate profitability with room for improvement
Decent operational efficiency, solid but not exceptional
Solid earnings growth at 17.30%
Decent profitability, keeps $15 per $100 revenue
Supporting Valuation Data
Balchem Corporation (BCPC) Detailed Analysis Report
Overall Assessment
This company scores 52/100 in our Smart Analysis, earning a C- grade. Out of 10 metrics analyzed, 2 register as strengths (avg 8.5/10) while 8 fall into concern territory (avg 4.6/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Institutional Own., Market Cap.
The Bear Case
The primary concerns are PEG Ratio, Price/Sales, Price/Book. Some valuation metrics including PEG Ratio (3.79), Price/Sales (5.18), Price/Book (4.13) suggest expensive pricing. Growth concerns include Revenue Growth at 9.80%, EPS Growth at 17.30%, which may limit upside. Profitability pressure is visible in Return on Equity at 12.90%, Operating Margin at 19.80%, Profit Margin at 14.90%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether PEG Ratio improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 12.90% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 9.80% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Institutional Own., Market Cap) and negatives (PEG Ratio, Price/Sales). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
BCPC Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
BCPC's Price-to-Sales ratio of 5.18x trades at a 20% premium to its historical average of 4.3x (79th percentile). The current valuation is 29% below its historical high of 7.25x set in Dec 2007, and 582% above its historical low of 0.76x in Aug 2006.
WallStSmart Analysis Synopsis
Data-driven financial summary for Balchem Corporation (BCPC) · BASIC MATERIALS › SPECIALTY CHEMICALS
The Big Picture
Balchem Corporation operates as a stable business with moderate growth and solid fundamentals. Revenue reached 1.0B with 10% growth year-over-year. Profit margins of 14.9% are healthy, with room for further expansion as the business scales.
Key Findings
ROE of 1290.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Generating 40M in free cash flow and 67M in operating cash flow. Earnings are translating into actual cash generation.
What to Watch Next
Margin expansion: can Balchem Corporation push profit margins above 15% as the business scales?
Sector dynamics: monitor SPECIALTY CHEMICALS industry trends, competitive moves, and regulatory changes that could impact Balchem Corporation.
Bottom Line
Balchem Corporation offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Balchem Corporation(BCPC)
NASDAQ
BASIC MATERIALS
SPECIALTY CHEMICALS
USA
Balchem Corporation develops, manufactures, and markets specialty ingredients and performance products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. The company is headquartered in New Hampton, New York.